Who Owns TransCode Therapeutics Stock?
NASDAQ: RNAZHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 0.44%
- Held by insiders
- 1.78%
- Institutional holders
- 9
- Institutions 0.4%
- Insiders 1.8%
- Public and other 97.8%
Who owns TransCode Therapeutics stock?
Institutional investors own about 0.4% of TransCode Therapeutics's shares, spread across 9 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 1.78% of RNAZ.
The largest institutional holders are Yorkville Advisors Global, LP (0.12%), Vanguard Capital Management LLC (0.04%) and Vanguard Fiduciary Trust Co (0.02%). Together, the top 8 institutions control 0.2% of shares outstanding. In their latest filings, 3 of the top 8 institutions increased their RNAZ positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of RNAZ
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Yorkville Advisors Global, LP | 19.64K | 0.12% | +100.0% |
| Vanguard Capital Management LLC | 6.54K | 0.04% | 0.0% |
| Vanguard Fiduciary Trust Co | 2.98K | 0.02% | 0.0% |
| UBS Group AG | 2.89K | 0.02% | -65.2% |
| FMR, LLC | 706 | 0.00% | +100.0% |
| Tower Research Capital LLC (TRC) | 677 | 0.00% | +196.9% |
| Wells Fargo & Company | 55 | 0.00% | 0.0% |
| SBI Securities Co., Ltd. | 12 | 0.00% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of RNAZ
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 6.54K | 0.04% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 5.11K | 0.03% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 1.18K | 0.01% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 510 | 0.00% |
Frequently asked questions
Who is the largest shareholder of TransCode Therapeutics?
Yorkville Advisors Global, LP is the largest institutional shareholder of RNAZ, owning 0.12% of shares outstanding (19.64K shares) as of its latest 13F filing.
What percentage of TransCode Therapeutics is owned by institutions?
Institutions own about 0.4% of RNAZ shares and 0.5% of the public float.
How much of TransCode Therapeutics do insiders own?
Insiders, such as officers and directors, own about 1.78% of RNAZ shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.